Novartis AG
Close on Nov 2, 2026Market cap $308.21BP/E 22.6Yield –
Novartis Net Sales Outside the US by Key Country Note
Net Sales Outside the US by Key Country Note (Form 20-F) ($M)
Novartis Net Sales Outside the US by Key Country Note: $31,201M in FY2025, up 7.0% from a year earlier.
Where the FY2025 figure comes from
Source: Novartis Form 20-F (0001114448-26-000004) ↗
Reported in Form 20-F Note 28 / Geographical information.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Net Sales Outside the US by Key Country Note (Form 20-F) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 31,201 | +7.0% | Novartis Form 20-F (0001114448-26-000004) ↗ |
| FY2024 | Dec 31, 2024 | 29,171 | +6.1% | Novartis Form 20-F (0001114448-26-000004) ↗ |
| FY2023 | Dec 31, 2023 | 27,481 | +4.6% | Novartis Form 20-F (0001114448-26-000004) ↗ |
| FY2022 | Dec 31, 2022 | 26,271 | -5.7% | Novartis Form 20-F (0001370368-25-000004) ↗ |
| FY2021 | Dec 31, 2021 | 27,858 | – | Novartis Form 20-F (0001370368-24-000004) ↗ |
Breakdown
What makes up net Sales Outside the US by Key Country Note
Cite this data
StockData. (2026). Novartis Net Sales Outside the US by Key Country Note ($M), annual FY2021–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/geo-country-rest-of-world-annual
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.